Refer a Friend
Don't forget to refer a friend or family member and receive $200 referral fee for each qualified referral.
Learn MoreFrontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.
This is a Phase 1 study to evaluate the safety and tolerability of Single ascending oral doses of CV-02 in healthy adult subjects. CV-02 is being developed for the possible treatment possible treatment for multiple sclerosis.